221 related articles for article (PubMed ID: 16300639)
1. c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion.
Zoukhri D; Macari E; Choi SH; Kublin CL
J Neurochem; 2006 Jan; 96(1):126-35. PubMed ID: 16300639
[TBL] [Abstract][Full Text] [Related]
2. Induction of nitric oxide synthase and over-production of nitric oxide by interleukin-1beta in cultured lacrimal gland acinar cells.
Beauregard C; Brandt PC; Chiou GC
Exp Eye Res; 2003 Jul; 77(1):109-14. PubMed ID: 12823994
[TBL] [Abstract][Full Text] [Related]
3. Roles of caspase 1 and extracellular signal-regulated kinase in inflammation-induced inhibition of lacrimal gland protein secretion.
Zoukhri D; Ko S; Stark PC; Kublin CL
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4392-8. PubMed ID: 18566460
[TBL] [Abstract][Full Text] [Related]
4. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia.
Zoukhri D; Hodges RR; Byon D; Kublin CL
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1429-36. PubMed ID: 11980857
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 mediates thermal injury-induced lung damage through C-Jun NH2-terminal kinase signaling.
Chen LW; Chang WJ; Wang JS; Hsu CM
Crit Care Med; 2007 Apr; 35(4):1113-22. PubMed ID: 17334237
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor agonists inhibit interleukin-1beta-mediated nitric oxide production in cultured lacrimal gland acinar cells.
Beauregard C; Brandt PC
J Ocul Pharmacol Ther; 2003 Dec; 19(6):579-87. PubMed ID: 14733715
[TBL] [Abstract][Full Text] [Related]
7. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
[TBL] [Abstract][Full Text] [Related]
8. Dry eye management in a Sjögren's syndrome mouse model by inhibition of p38-MAPK pathway.
Ma X; Zou J; He L; Zhang Y
Diagn Pathol; 2014 Jan; 9():5. PubMed ID: 24443980
[TBL] [Abstract][Full Text] [Related]
9. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
Zoukhri D; Kublin CL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
11. JNK signaling involved in the effects of cyclic AMP on IL-1beta plus IFNgamma-induced inducible nitric oxide synthase expression in hepatocytes.
Zhang B; Perpetua M; Fulmer M; Harbrecht BG
Cell Signal; 2004 Jul; 16(7):837-46. PubMed ID: 15115662
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord.
Sung CS; Wen ZH; Chang WK; Chan KH; Ho ST; Tsai SK; Chang YC; Wong CS
J Neurochem; 2005 Aug; 94(3):742-52. PubMed ID: 16033422
[TBL] [Abstract][Full Text] [Related]
13. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
14. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta signals through a c-Jun N-terminal kinase-dependent inducible nitric oxide synthase and nitric oxide production pathway in Sertoli epithelial cells.
Ishikawa T; Morris PL
Endocrinology; 2006 Nov; 147(11):5424-30. PubMed ID: 16887914
[TBL] [Abstract][Full Text] [Related]
16. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
17. A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation.
Zoukhri D; Macari E; Kublin CL
Exp Eye Res; 2007 May; 84(5):894-904. PubMed ID: 17362931
[TBL] [Abstract][Full Text] [Related]
18. Down regulation of interleukin-1beta-induced nitric oxide production in lacrimal gland acinar cells by sex steroids.
Beauregard C; Brandt P
Curr Eye Res; 2004 Jul; 29(1):59-66. PubMed ID: 15370368
[TBL] [Abstract][Full Text] [Related]
19. Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.
Zhou J; Jin JO; Du J; Yu Q
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7831-8. PubMed ID: 26658504
[TBL] [Abstract][Full Text] [Related]
20. Lacrimal Gland Histopathology and Secretory Function in Sjögren's Syndrome Mice Model Treated with
Susanto AJ; Purwanto B; Mudigdo A; Wasita B
Antiinflamm Antiallergy Agents Med Chem; 2023; 21(3):166-172. PubMed ID: 36305140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
